Autoimmune Cardiotoxicity of Cancer Immunotherapy
- 2 December 2016
- journal article
- Published by Elsevier BV in Trends in Immunology
- Vol. 38 (2), 77-78
- https://doi.org/10.1016/j.it.2016.11.007
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Fulminant Myocarditis with Combination Immune Checkpoint BlockadeNew England Journal of Medicine, 2016
- Cardiovascular Toxic Effects of Targeted Cancer TherapiesNew England Journal of Medicine, 2016
- Cancer experts unveil wishlist for US government ‘moonshot’Nature, 2016
- Precision medicine in cardiologyNature Reviews Cardiology, 2016
- Cocktails for cancer with a measure of immunotherapyNature, 2016
- Regulatory T cells in cardiovascular diseasesNature Reviews Cardiology, 2015
- Combination cancer immunotherapy and new immunomodulatory targetsNature Reviews Drug Discovery, 2015
- Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanomaJournal for ImmunoTherapy of Cancer, 2015
- The future of immune checkpoint therapyScience, 2015
- Immunotherapy of autoimmunity and cancer: the penalty for successNature Reviews Immunology, 2008